bluebird bio, Inc. (BLUE): Price and Financial Metrics
BLUE Price/Volume Stats
Current price | $7.12 | 52-week high | $38.40 |
Prev. close | $7.27 | 52-week low | $5.80 |
Day low | $6.95 | Volume | 149,300 |
Day high | $7.55 | Avg. volume | 198,471 |
50-day MA | $8.07 | Dividend yield | N/A |
200-day MA | $13.28 | Market Cap | 69.22M |
BLUE Stock Price Chart Interactive Chart >
bluebird bio, Inc. (BLUE) Company Bio
Bluebird Bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies. The company was founded in 1992 and is based in Cambridge, Massachusetts.
BLUE Price Returns
1-mo | N/A |
3-mo | 19.50% |
6-mo | -48.31% |
1-year | -67.64% |
3-year | -94.19% |
5-year | -99.56% |
YTD | -14.63% |
2024 | -69.78% |
2023 | -80.06% |
2022 | -30.73% |
2021 | -76.91% |
2020 | -50.69% |
Continue Researching BLUE
Want to do more research on bluebird bio Inc's stock and its price? Try the links below:bluebird bio Inc (BLUE) Stock Price | Nasdaq
bluebird bio Inc (BLUE) Stock Quote, History and News - Yahoo Finance
bluebird bio Inc (BLUE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...